Considered as revolutionary examination to analyze the risk of the most common fetal trisomies and for aneuploidy X, Y, Harmony prenatal test is non-invasive and presents no risk because you use a sample of the mother’s blood from the 10th week of her pregnancy, onwards.
After performing a simple test using the mother’s blood, you can proceed directly with an analysis of fetal DNA, given that it is also circulates in the blood of the mother during pregnancy. The DNA analysis allows you to identify the risk of trisomies 21, 18 and 13 aneuploidies of chromosomes X, Y of the fetus, but not all fetal chromosomal abnormalities.

The examination is based on the most recent developments in non-invasive prenatal testing and has demonstrated a high reliability: over 99% in determining the risk of trisomy 21 (Down Syndrome), 98% for trisomy 18 (Edwards Syndrome) and 80% for trisomy 13 (Patau Syndrome). In all three cases, the false positive rate is less than 0.1%. The Harmony Test also allows you to extract information on the gender of the fetus and aneuploidy X, Y.

You can have the test results within 15 days, through a report that clearly highlights the degree of risk for such genetic abnormalities.
If the test revealed a too high risk, then you should not assume that the pregnancy is positive for one of the anomalies analyzed. The gynecologist will offer genetic counseling and recommend any further diagnostic tools used to determine, with certainty, the presence of any anomalies. The rate of false positives found with the Harmony Test is 50 times lower than that of the current screening tests. Therefore, it minimizes the risk of having to unnecessarily undergo invasive diagnostic procedures such as amniocentesis or chorionic villus sampling.